The European Journal of Emergency Medicine

3 weeks ago | journals.lww.com | Gina Shaw

Article In BriefA new approval for an oral therapy for a disease-modifying therapy for spinal muscular atrophy elicited discussion about whether oral therapies have changed the treatment landscape for neurogenetic disorders. Experts said the answer varies depending on the therapy and condition. The US Food and Drug Administration (FDA) has approved a new tablet form of Genentech's spinal muscular atrophy (SMA) treatment risdiplam (Evrysdi) for patients ages 2 and older.

3 weeks ago | journals.lww.com | Lola Butcher

Article In BriefAs the needs of neurology patients have become increasingly complex, many neurology clinics now include an array of multidisciplinary services and specialists. The clinics provide a boost to patient care by providing the array of services under one department. Multidisciplinary clinics, long used to care for patients with high-disability neurologic conditions, are increasingly being developed to improve patient care for other groups of patients.

3 weeks ago | journals.lww.com | Gina Shaw

Article In BriefIn February, researchers conducting research involving diverse, underrepresented populations received notices from various NIH agencies that their grants had been cancelled or cut. Leaders in the field of diversity, equity, inclusion (DEI) discuss the downstream effect of these cuts and the commitment of the AAN to promoting DEI in research and recruitment.

3 weeks ago | journals.lww.com | Dan Hurley

Article In BriefA new study found that people younger than 75 years old had a 73 percent increase in the risk of developing dementia for each additional microgram per cubic meter exposure to wildfire smoke. The study author urged neurologists in wildfire-prone areas to educate their patients about the need to minimize time outside in smoky conditions, to wear a fitted N-95 or KN95 mask, and to have an air filtration system in their home.

3 weeks ago | journals.lww.com | Dan Hurley

Article In BriefTwo new papers found the greater number of repeat expansions within the CASP8 gene produced toxic aggregates called polyGlycineArginine proteins, which were associated with an increased risk of Alzheimer's disease. Independent experts said that if these findings are confirmed in other research papers, clinicians will need to look for more of these expansions.